Top compounds associated with response to B9D2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.03
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.03
mRNA indisulam CTRPv2 pan-cancer AAC 0.074 0.03
mRNA paclitaxel CCLE pan-cancer AAC 0.1 0.03
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.07 0.03
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.03
mRNA erastin CTRPv2 pan-cancer AAC -0.079 0.03
mRNA TKI258 CCLE pan-cancer AAC 0.1 0.03
mRNA T0901317 GDSC1000 pan-cancer AAC 0.072 0.03
mRNA RITA CTRPv2 pan-cancer AAC 0.08 0.03
Download CSV